Common use of Milestone Event Milestone Payment Clause in Contracts

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.5 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the Acceptance for a [**] for a Engineered T-Cell Product that differs from the Class of [**]Engineered T-Cell Product that differs was the subject of Milestone Event A.2 above on the basis of clause (a) of Section 1.21 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ba) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target 1.21 [**]

Milestone Event Milestone Payment. 111. First [**] filing with the [**] for a subsequent Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event B.1 D.7 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 111. First [**] filing with the [**] for a subsequent Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event B.1 D.7 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]Target

Milestone Event Milestone Payment. 1. First [**] filing with the Acceptance for a [**] for a Class of [**]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.15 but is the same Class as and from the Class of [**] ]Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. 111. First [**] filing with the [**] for a subsequent Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event B.1 D.7 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 13. First [**] filing with the [**] for a Class of each [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ba) of Section 1.15 but is the same Class as 1.21 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.21 [**]

Milestone Event Milestone Payment. 1. First [**] filing with the Acceptance for a [**] for a Class of [**]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.15 but is the same Class as 1.21 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.21 [**]

Milestone Event Milestone Payment. 17. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 D.3 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 15. First [**] filing with from the [**] for a Class of for each [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ba) of Section 1.15 but is the same Class as and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. 17. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 D.3 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 17. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 D.3 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]

Milestone Event Milestone Payment. 1. First [**] filing with the Acceptance for a [**] for a Class of [**]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.15 but is the same Class as and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]